<DOC>
	<DOCNO>NCT01144819</DOCNO>
	<brief_summary>Background : Dual antithrombotic treatment aspirin clopidogrel recommend patient ST elevation myocardial infarction ( STEMI ) undergo primary percutaneous coronary intervention ( PCI ) . The European Society Cardiology ( ESC ) Guidelines recommend bolus dose aspirin 250-500 mg 600 mg bolus dose clopidogrel soon STEMI suspect . Studies show newly produce platelet present acute phase STEMI , likely immature platelet haemostatically active might importance thrombus formation . The enhanced platelet reactivity may reduce effect aspirin clopidogrel acute phase STEMI compare measurement make patient 3 month primary PCI . Aim : This study aim compare platelet response aspirin clopidogrel acute phase STEMI platelet response patient 3 month STEMI . Design : This study observational follow-up study . Materials method : 46 patient STEMI refer primary PCI Aarhus University Hospital , Skejby include study . A total 3 blood sample obtain acute phase STEMI : Prior primary PCI ( Blood sample 1 ) , 4 hour ( Blood sample 2 ) 12 hour ( Blood sample 3 ) administration load dose aspirin clopidogrel . When patient stable phase 3 month later , final blood sample take ( Blood sample 4 ) . The blood analyze 30 minute withdrawal blood platelet aggregation test Multiplate® aggregometry ( agonist : Collagen , arachidonic acid adenosinediphosphate ) VerifyNow® arachidonic acid P2Y12 aggregometry . Platelet count , volume immature platelet fraction ( IPF ) measure use Sysmex® flowcytometry .</brief_summary>
	<brief_title>Platelet Inhibition Acute Phase STEMI</brief_title>
	<detailed_description />
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<criteria>Above 18 year age Patients STsegment elevation myocardial infarction ( STEMI ) refer primary PCI University Hospital Aarhus , Skejby . Treatment NSAID , ticlopidine dipyramidole . Treatment anticoagulant ( Vitamin K antagonist ) Patients diagnosed platelet disease haemophilia . Patients unable give write , informed consent participation project .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>STEMI</keyword>
	<keyword>Acute myocardial infarction</keyword>
	<keyword>Antiplatelet therapy</keyword>
	<keyword>aspirin</keyword>
	<keyword>clopidogrel</keyword>
	<keyword>VerifyNow aggregometry</keyword>
	<keyword>Multiplate aggregometry</keyword>
</DOC>